Daito Pharmaceutical Co.,Ltd. (TYO:4577)
Japan · Delayed Price · Currency is JPY 1,242.00
+2.00 (0.16%)
Aug 4, 2026, 11:07 AM JST
Daito Pharmaceutical Financials Overview
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Revenue Revenue Growth | 50,650 | 50,650 | 50,643 | 46,895 | 45,101 | 43,464 |
Revenue Growth | 0.01% | 0.01% | 7.99% | 3.98% | 3.77% | -10.78% |
Gross Profit Gross Profit Growth | 9,897 | 9,897 | 8,638 | 9,839 | 10,331 | 11,459 |
Operating Income Operating Income Growth | 3,637 | 3,637 | 2,621 | 3,894 | 5,212 | 6,568 |
Net Income Net Income Growth | 3,161 | 3,161 | 1,908 | 3,295 | 3,600 | 4,668 |
Earnings Per Share EPS Growth | 107.46 | 107.46 | 62.72 | 105.00 | 113.71 | 152.45 |
EPS Growth | 71.34% | 71.34% | -40.27% | -7.67% | -25.41% | 7.85% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Cash & Investments Cash & Investments Growth | 954 | 954 | 2,207 | 2,727 | 3,607 | 4,381 |
Total Debt Total Debt Growth | 9,294 | 9,294 | 11,885 | 8,719 | 4,958 | 3,447 |
Net Cash (Debt) Net Cash Growth | -8,340 | -8,340 | -9,678 | -5,992 | -1,351 | 934 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -283.53 | -283.53 | -318.14 | -190.94 | -42.68 | 30.50 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 9,377 | 9,377 | 5,897 | 5,182 | 4,155 | 4,370 |
Capital Expenditures CapEx Growth | -3,849 | -3,849 | -6,789 | -6,220 | -5,505 | -4,627 |
Free Cash Flow Free Cash Flow Growth | 5,528 | 5,528 | -892 | -1,038 | -1,350 | -257 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | May '26 May 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Gross Margin | 19.54% | 19.54% | 17.06% | 20.98% | 22.91% | 26.36% |
Operating Margin | 7.18% | 7.18% | 5.17% | 8.30% | 11.56% | 15.11% |
Pretax Margin | 8.02% | 8.02% | 5.84% | 9.00% | 11.26% | 15.46% |
Profit Margin | 6.24% | 6.24% | 3.77% | 7.03% | 7.98% | 10.74% |
FCF Margin | 10.91% | 10.91% | -1.76% | -2.21% | -2.99% | -0.59% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 45.000 | 40.000 | 35.000 | 30.000 | 27.273 | 22.727 |
Dividend Per Share Growth | -23.81% | 14.29% | 16.67% | 10.00% | 20.00% | 8.70% |
Dividend Yield | 3.59% | 3.33% | 3.67% | 2.88% | 2.87% | 2.15% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
PE Ratio | 11.54 | 10.97 | 15.48 | 10.33 | 9.19 | 7.96 |
Forward PE | 13.98 | 13.33 | 15.15 | 8.98 | 9.39 | 8.00 |
P/FCF Ratio | 6.45 | 6.27 | - | - | - | - |
PS Ratio | 0.70 | 0.68 | 0.58 | 0.73 | 0.73 | 0.86 |